Axon895
发表于 2025-3-25 06:06:56
Personalized Cancer Therapy,on various omics such as genomics, proteomics, and metabolomics and biomarkers. The aim of the personalized medicine is to match the right drug to the right patient. The broad scope of personalized medicine includes predisposition testing, determination of prognosis, combination of diagnostics with therapeutics, and monitoring of therapy.
Intellectual
发表于 2025-3-25 08:27:25
https://doi.org/10.1007/978-3-322-81849-2apy. The cells may be introduced by various routes into the body and selectively implanted at the site of action. More recently, cell therapies have expanded to replace some conventional procedures. Bone marrow (BM) transplants are being replaced by peripheral blood stem cell (PBSC) transplants. Mos
organism
发表于 2025-3-25 12:51:45
http://reply.papertrans.cn/16/1594/159315/159315_23.png
ASSAY
发表于 2025-3-25 18:39:41
http://reply.papertrans.cn/16/1594/159315/159315_24.png
harbinger
发表于 2025-3-25 20:23:45
http://reply.papertrans.cn/16/1594/159315/159315_25.png
包庇
发表于 2025-3-26 04:07:47
Oncology. serves as an ideal reference for oncologists, scientists involved in research on cancer biology, and physicians in various specialties who deal with cancer.978-1-4939-4890-1978-1-4614-9245-0
Odyssey
发表于 2025-3-26 06:05:06
http://reply.papertrans.cn/16/1594/159315/159315_27.png
enumaerate
发表于 2025-3-26 10:07:00
http://reply.papertrans.cn/16/1594/159315/159315_28.png
集聚成团
发表于 2025-3-26 14:33:58
http://reply.papertrans.cn/16/1594/159315/159315_29.png
疏远天际
发表于 2025-3-26 19:52:06
Role of Biotechnology in Drug Delivery for Cancer,herapies, require new concepts of drug delivery in cancer. New biotechnologies have contributed considerably to drug delivery in cancer and some of these have been considered in other chapters: monoclonal antibodies (MAbs) (Chap. 8), nanobiotechnology/nanooncology (Chap. 9), cell therapy (Chap. 10),